突变特征定义了皮癌的免疫和Wnt相关亚型
Ekaterina Zhuravleva1, Monika Lewinska1, Colm J O'Rourke1
1Biotech Research and Innovation Center (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Gut
|December 26, 2024
概括
我们根据突变特征确定了三种囊癌 (AMPAC) 的分子亚型,提供了新的预后见解. 这种分类可以指导个性化治疗,区分那些可以从免疫疗法或Wnt途径抑制剂中受益的患者.
科学领域:
- 基因组医学是一种基因组医学.
- 在瘤学瘤学.
- 分子病理学分子病理学
背景情况:
- 目前的膜癌 (AMPAC) 分类依赖于形态学和免疫组织化学,缺乏预后准确性和明显的遗传关联.
- 综合基因组学提供了一种潜在的方法来描述AMPAC,并确定个性化治疗策略的分子亚型.
研究的目的:
- 应用整合性基因组学来表征皮癌 (AMPAC) 患者,并确定分子亚型.
- 探索可能指导AMPAC个性化治疗决策的分子亚型.
主要方法:
- 在170名AMPAC患者中分析突变格局 (110个瘤/正常对用于发现,60个用于验证).
- 在瘤子集中对转录组和DNA甲基组进行审讯.
- 基于突变特征的患者分层,与分子和临床特征相关,包括瘤和免疫细胞性评估.
主要成果:
- 三个患者群 (C1,C2,C3) 由不同的突变特征定义,独立于组织形态学.
- 集群1 (C1) 呈现自发去胺和缺陷不匹配修复;集群2和3 (C2,C3) 显示转录合的核酸切除修复活性,C3 额外由聚合酶乙酸活性定义.
- C1-2与Wnt通路的改变,异常的DNA甲基化,免疫排除和不良预后有关,与超级突变体表型相关. C3患者的生存率提高,免疫透率提高,免疫抑制检查点基因的表达增加.
结论:
- 突变特征突出显示免疫性和Wnt通路关联,预测对免疫疗法或Wnt通路抑制剂的敏感性.
- 基于突变特征的AMPAC新型分类显示出预后潜力.
- 这种方法可能会导致囊癌患者的分组特定的管理策略.
相关概念视频
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
01:41Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K